Recently, the Phase III clinical trial for pediatric indication of Deunoxavir Marboxil, an innovative anti-influenza drug jointly developed by Simcere Pharmaceutical and AnDiConBio, marked the successful administration of the drug to its first patient at Liuzhou People's Hospital. Deunoxavir Mar...
Preliminary safety and efficacy data from this trial were previously presented at the European Society for Medical Oncology (ESMO) Congress in 2023. MK-1084 is being developed through a collaboration with Taiho Ph...
alongside a direct presence in select other markets across the globe. EUSA Pharma is led by an experienced management team with a strong record of building successful pharmaceutical companies,
phase 3completion timesorganizational sizeBackground: The pharmaceutical industry has continued to experience a large number of mergers, often involving the very largest companies. Behind many of thesedoi:10.1177/2168479016648733Glass, H. EGlass, L. M...
From the mid-1970s the pharmaceutical industry has played a reduced role in contraceptive development because time-consuming preclinical requirements and o... G Benagiano,G Perkin,M Potts - 《Female Contraception Update & Trends》 被引量: 0发表: 1988年 ...
Recently, the Phase III clinical trial scheme discussion of recombinant human erythropoietin -Fc fusion protein for injection (hereinafter referred to as "rhEPO-Fc fusion protein") jointly conducted by Beijing New Leading Zhengzhou Deep Blue Sea and Shandong Danhong Pharmaceutical (a wholly-owned ...
Celltrion said on Monday that it submitted a phase 3 investigational new drug (IND) plan to the U.S. Food and Drug Administration (FDA) for CT-P53, a biosimilar of the multiple sclerosis drug, Ocrevus (ingredient: ocrelizumab). (Credit: Celltrion) The phase 3 global clinical trial of ...
Johnson & Johnson initiates second global Phase 3 clinical trial of its Janssen COVID-19 vaccine candidate The Phase 3 ENSEMBLE study of the single-dose regimen of JNJ-78436735, the investigational vaccine candidate for the prevention of COVID-19 being developed by...
The opening ceremony of phase three clinical trials for the inactivated vaccine, which may consist of whole, inactivated agents developed by China National Pharmaceutical Group Sinopharm (Sinopharm) was held online in China's Beijing and Wuhan, and the UAE's Abu Dhabi on Tuesday. Abdul Rahman Moh...
Marinus Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders. Ganaxolone is a positive allosteric modulator of GABAA receptors that acts on a well-characterized target in the brain known to have anti-seizure, antidepress...